Good Life Advisors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-3,065
| Closed | -$239K | – | 492 |
|
|
2024
Q3 | $239K | Buy |
+3,065
| New | +$239K | 0.01% | 518 |
|
|
2023
Q3 | – | Sell |
-5,148
| Closed | -$368K | – | 416 |
|
|
2023
Q2 | $368K | Hold |
5,148
| – | – | 0.04% | 273 |
|
|
2023
Q1 | $357K | Sell |
5,148
-794
| -13% | -$55.1K | 0.05% | 266 |
|
|
2022
Q4 | $403K | Sell |
5,942
-406
| -6% | -$27.5K | 0.06% | 226 |
|
|
2022
Q3 | $348K | Buy |
6,348
+64
| +1% | +$3.51K | 0.05% | 234 |
|
|
2022
Q2 | $415K | Sell |
6,284
-200
| -3% | -$13.2K | 0.06% | 219 |
|
|
2022
Q1 | $430K | Sell |
6,484
-231
| -3% | -$15.3K | 0.05% | 231 |
|
|
2021
Q4 | $391K | Buy |
6,715
+33
| +0.5% | +$1.92K | 0.05% | 245 |
|
|
2021
Q3 | $401K | Buy |
+6,682
| New | +$401K | 0.05% | 232 |
|